| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b787ed6b2bb37df983cad8522fd7408 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcaa7e5ac6f91abdcf23d279d5f7a9f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad9e13d64f59409dcd561f09186fafb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e862e629f5643a20ba430ad2e53807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa452ed0c0844ce449c815e6a4ae4f98 |
| publicationDate |
2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020281949-A1 |
| titleOfInvention |
Methods for treating castration-resistant and castration-sensitive prostate cancer |
| abstract |
or a pharmaceutically acceptable salt or zwitterionic form thereof, are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022221661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11518747-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11530231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497756-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779550-B2 |
| priorityDate |
2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |